By @JonPicciniSr - In #HFrEF: #Castle_AF: PVI⬇️death&hospitalization
Catheter Ablation for Atrial Fibrillation with Heart Failure.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jan 2018 – Aug 2024Where it's discussed
-
X / Twitter76 posts
-
News24 articles
-
Facebook20 posts
-
Blogs6 articles
-
YouTube4 videos
-
Bluesky1 posts
AI synopsis
What people are saying
The texts demonstrate strong agreement and active engagement with the article, often referencing specific trials like CASTLE-AF to support claims of ablation's benefits in heart failure, with words like 'impressive' and 'benefit' illustrating the high impact they believe the research has on clinical practice and patient outcomes.
Most discussions reflect strong support for the significance of the study, with many emphasizing its positive outcomes and potential to change clinical practice.
The discussions show high interest by referencing specific trials like CASTLE-AF and CABANA, mentioning survival curves, and highlighting the importance of ablation in treating patients with heart failure and atrial fibrillation.
Participants actively analyze the data, question the results, and compare findings across various studies, indicating deep engagement with the research.
The posts suggest a high perceived impact, as many call the research 'impressive,' 'game-changing,' or highlight statistical benefits such as reduced mortality and hospitalization.
Abstract in brief
- Catheter ablation significantly reduced the risk of death or hospitalization for worsening heart failure in patients with atrial fibrillation and heart failure compared to standard medical therapy.
- Patients who underwent ablation had lower rates of death from any cause, hospitalization for worsening heart failure, and cardiovascular death during a median follow-up of about 3.8 months.
- The study suggests that catheter ablation can be an effective treatment option to improve outcomes in heart failure patients with atrial fibrillation who do not respond well to medication.]
Top posts
Most liked on X and BlueskyHFrEF+AF アブレーション CAMTAF https://t.co/QlNFvsfi1I AATAC vs アミオダロン https://t.co/hwLQ8dvKA5 CASTLE-AF 予後 vs アミオダロン https://t.co/RE4YpZwEen ※LVEF≥25, Age≤65, NYHA II 軽度のHFrEFに良い
CAMERA-MRI https://t.co/dk9iRUwhsv CASTLE-AF https://t.co/l5hLrvLfdr CABANA https://t.co/CYwTy3VuST CIRCA-DOSE https://t.co/XS0nGtJv0z Alcohol abstinence in AF https://t.co/Fevj4aKRfr #WAfib2020
#AFibAwareness Both randomized and observational studies demonstrated a significant benefit of catheter ablation in patients with HF.The biggest one was CASTLE AF.patients should be seen by cardiologist/electrophysiologist early in the care process https://t.co/Hda3tUpuFM https://t.co/Wb9GBy1xNi
risk ratioが時間で変わっていく=proportional hazardでない ということが仮定されていなかったこと!! CASTLE-AFのFigure 2をみれば歴然(当然本研究の計画後にpublishされたものだが) (続 https://t.co/OeBvb3JRC1
@DanielAlyeshmer @NEJM @Dr_Santangeli @srissundaram @DrGregMichaud @Zo_EP2 @EJSMD @bogdienache @HamidGhanbariMD @KanwarAulakh @CarinaHardy4 Although it may seem intuitive that VT ablation would result in a mortality benefit, this has been difficult to prove. @DrRoderickTung is working on it though. If they have HF and also happen to have AF, then apparently AF ablation is life saving. https://t.co/gRLlO4YtIq
All mentions
Comparative Effectiveness of Atrial Fibrillation Ablation Methods
This video examines who is an appropriate candidate for atrial fibrillation and the most successful treatment methods. Dr. William Hucker discusses contact force-guided radiofrequency and cryoballoon ablation…
GLP1 Agonists and Heart Failure Insights for Healthcare Professionals
This week, John Mandrola MD discusses suicidal ideation associated with GLP1 agonists, focusing on the implications for healthcare professionals. He also revisits the PARADIGM HF study and explores insights from recent…
New Insights on Atrial Fibrillation and Treatment Strategies
This week, John Mandrola MD discusses three key aspects of the recent AF guidelines, emphasizing early rhythm-control therapy's potential to reduce cardiovascular risks. Join us for an in-depth analysis of the latest…
Ablation vs Rate Control in Heart Failure with Atrial Fibrillation
This podcast discusses the RAFT-AF trial, which compared ablation-based rhythm control versus rate control in heart failure patients with atrial fibrillation. While the study showed no significant differences in primary…
Estudios previos han demostrado el beneficio de la ablación de la fibrilación auricular en pacientes con insuficiencia cardíaca menos avanzada Marrouche NF, Brachmann J, Andresen D, et al. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med 2018;378:417-27. https://t.co/A1Od3Sd5uG
@SwissHeartDoc https://t.co/jqtJwQ3j1i castle af, catheter ablation x rate control in hf patients. https://t.co/WcBNrpoZVc early afnet. Benefit in rhythm control in af < 1 year of diagnosis
@SwissHeartDoc not totally rate vs rhythm controle: https://t.co/hqYbcpxuna
@MergencyFe https://t.co/faThIy6553
RT @jsenior64: Lo primero que llama la atención es el comportamiento de las curvas durante los primeros meses. Van superpuestas hasta despu…
Lo primero que llama la atención es el comportamiento de las curvas durante los primeros meses. Van superpuestas hasta después de los 6 meses. ¿Alguna razón para explicar el fenómeno? La tasa de eventos fue menor que el esperado y se detuvo el estudio. https://t.co/bauwuytPRO https://t.co/bIEyIkGoGF
RT @Crypto1835: HFrEF+AF アブレーション CAMTAF https://t.co/QlNFvsfi1I AATAC vs アミオダロン https://t.co/hwLQ8dvKA5 CASTLE-AF 予後 vs アミオダロン https:/…
RT @Crypto1835: HFrEF+AF アブレーション CAMTAF https://t.co/QlNFvsfi1I AATAC vs アミオダロン https://t.co/hwLQ8dvKA5 CASTLE-AF 予後 vs アミオダロン https:/…
RT @Crypto1835: HFrEF+AF アブレーション CAMTAF https://t.co/QlNFvsfi1I AATAC vs アミオダロン https://t.co/hwLQ8dvKA5 CASTLE-AF 予後 vs アミオダロン https:/…
RT @Crypto1835: HFrEF+AF アブレーション CAMTAF https://t.co/QlNFvsfi1I AATAC vs アミオダロン https://t.co/hwLQ8dvKA5 CASTLE-AF 予後 vs アミオダロン https:/…
RT @Crypto1835: HFrEF+AF アブレーション CAMTAF https://t.co/QlNFvsfi1I AATAC vs アミオダロン https://t.co/hwLQ8dvKA5 CASTLE-AF 予後 vs アミオダロン https:/…
HFrEF+AF アブレーション CAMTAF https://t.co/QlNFvsfi1I AATAC vs アミオダロン https://t.co/hwLQ8dvKA5 CASTLE-AF 予後 vs アミオダロン https://t.co/RE4YpZwEen ※LVEF≥25, Age≤65, NYHA II 軽度のHFrEFに良い
RT @NaokiThukishima: #23jcs #AFablationの歴史と展望-13 =AF ablation後の予後を検討したRCT= *CASTLE-AF https://t.co/1QV8HKhjul *CABANA https://t.co/VJNuWz…
#23jcs #AFablationの歴史と展望-13 =AF ablation後の予後を検討したRCT= *CASTLE-AF https://t.co/1QV8HKhjul *CABANA https://t.co/VJNuWzMNuj https://t.co/tnSln2K6zQ *EAST-AFNET4 https://t.co/H2r0DLE3Yw https://t.co/2tUfi8WBNz
@morito80460384 https://t.co/iEy3gFu51Q
RT @megikaya: risk ratioが時間で変わっていく=proportional hazardでない ということが仮定されていなかったこと!! CASTLE-AFのFigure 2をみれば歴然(当然本研究の計画後にpublishされたものだが) (続 ht…
risk ratioが時間で変わっていく=proportional hazardでない ということが仮定されていなかったこと!! CASTLE-AFのFigure 2をみれば歴然(当然本研究の計画後にpublishされたものだが) (続 https://t.co/OeBvb3JRC1
RT @AnneNeubert1: 2/ Catheter Ablation for Atrial Fibrillation with Heart Failure @nmarrouche https://t.co/I71ctdT18V
2/ Catheter Ablation for Atrial Fibrillation with Heart Failure @nmarrouche https://t.co/I71ctdT18V
@ProfDConnelly @narrowQRS As Prof Connelly points out - the statistical fragility in the context of the number lost to follow-up and cross-overs means confirmatory data are required from adequately powered, randomised (and ? sham-controlled) trials. See our letter re. CASTLE-AF https://t.co/8jjBDT6fMR
11/ For Heart Failure Catheter Ablation for Atrial Fibrillation with Heart Failure - @nmarrouche https://t.co/I71ctdT18V
@chentemorales https://t.co/9o42Vh8Uf1
RT @Dominik_Linz: By @JonPicciniSr - In #HFrEF: #Castle_AF: PVI⬇️death&hospitalization
RT @Dominik_Linz: By @JonPicciniSr - In #HFrEF: #Castle_AF: PVI⬇️death&hospitalization
RT @Dominik_Linz: By @JonPicciniSr - In #HFrEF: #Castle_AF: PVI⬇️death&hospitalization
RT @Dominik_Linz: By @JonPicciniSr - In #HFrEF: #Castle_AF: PVI⬇️death&hospitalization
RT @Dominik_Linz: By @JonPicciniSr - In #HFrEF: #Castle_AF: PVI⬇️death&hospitalization
RT @Dominik_Linz: By @JonPicciniSr - In #HFrEF: #Castle_AF: PVI⬇️death&hospitalization
RT @Dominik_Linz: By @JonPicciniSr - In #HFrEF: #Castle_AF: PVI⬇️death&hospitalization
RT @Dominik_Linz: By @JonPicciniSr - In #HFrEF: #Castle_AF: PVI⬇️death&hospitalization
RT @Dominik_Linz: By @JonPicciniSr - In #HFrEF: #Castle_AF: PVI⬇️death&hospitalization
RT @Dominik_Linz: By @JonPicciniSr - In #HFrEF: #Castle_AF: PVI⬇️death&hospitalization
RT @Dominik_Linz: By @JonPicciniSr - In #HFrEF: #Castle_AF: PVI⬇️death&hospitalization
By @JonPicciniSr - In #HFrEF: #Castle_AF: PVI⬇️death&hospitalization
CASTLE AF Trial https://t.co/jNUFdS5mPO STOP-AF Trial https://t.co/EKqH14IPtG CABANA Trial https://t.co/iujA0N8obT
RT @cardioimpulso: https://t.co/Cp7D07Y9Jp https://t.co/O88OxvAxRo
RT @cardioimpulso: https://t.co/Cp7D07Y9Jp https://t.co/O88OxvAxRo
https://t.co/Cp7D07Y9Jp https://t.co/O88OxvAxRo
@JonPicciniSr @DanMarkMD @noseworthypeter @jepoolemd @DCRINews Ref: https://t.co/02uTwxuJda https://t.co/K8AHz7pXtK
@JonPicciniSr @DanMarkMD @noseworthypeter @jepoolemd @DCRINews Great! Similar positive outcome (plus improvement in EF%) in AF patients with severe LV impairment in the CASTLE-AF study. Ref: https://t.co/02uTwxuJda
RT @AnneNeubert1: 7/ Catheter Ablation for Atrial Fibrillation with Heart Failure @nmarrouche https://t.co/I71ctdT18V Nassir F Marrouche
7/ Catheter Ablation for Atrial Fibrillation with Heart Failure @nmarrouche https://t.co/I71ctdT18V Nassir F Marrouche
心房細動や心不全患者に対する心房細動アブレーションが左室機能改善と有害転帰減少をもたらすとする小規模な研究*や、また抗不整脈薬のドロネダロンがプラセボより死亡と心血管疾患入院を減らしたとする研究があります。 https://t.co/Bd5yoB1JhR https://t.co/MfpZZC4nla
@sameerbansilal @MKIttlesonMD @AndrewJSauer @DrNasrien @AminYehyaMD @JeffHsuMD @DevinMehta @JDMossMD @B_Naz_MD @gregorymmarcus @shwinner @SusanJosephMD @datsunian and of course CASTLE-AF. https://t.co/wip6okYWQu
RT @MDTolgaAksu: #AFibAwareness Both randomized and observational studies demonstrated a significant benefit of catheter ablation in patien…
RT @MDTolgaAksu: #AFibAwareness Both randomized and observational studies demonstrated a significant benefit of catheter ablation in patien…
RT @MDTolgaAksu: #AFibAwareness Both randomized and observational studies demonstrated a significant benefit of catheter ablation in patien…
RT @MDTolgaAksu: #AFibAwareness Both randomized and observational studies demonstrated a significant benefit of catheter ablation in patien…
RT @MDTolgaAksu: #AFibAwareness Both randomized and observational studies demonstrated a significant benefit of catheter ablation in patien…
#AFibAwareness Both randomized and observational studies demonstrated a significant benefit of catheter ablation in patients with HF.The biggest one was CASTLE AF.patients should be seen by cardiologist/electrophysiologist early in the care process https://t.co/Hda3tUpuFM https://t.co/Wb9GBy1xNi
RT @CardioVisualApp: A new study shows benefits of minimally invasive catheter-based ablation in a patient with afib and heart failure over…
A new study shows benefits of minimally invasive catheter-based ablation in a patient with afib and heart failure over medication treatment. Read more: https://t.co/dZWTv7Pki4 #hcsm #ReliableInformation #MedicalApps #CaseStudy #VirtualHealthcare #SmartPatients #CardioVisual https://t.co/NzcdDQTTZt
RT @netta_doc: CAMERA-MRI https://t.co/dk9iRUwhsv CASTLE-AF https://t.co/l5hLrvLfdr CABANA https://t.co/CYwTy3VuST CIRCA-DOSE https://t…
RT @netta_doc: CAMERA-MRI https://t.co/dk9iRUwhsv CASTLE-AF https://t.co/l5hLrvLfdr CABANA https://t.co/CYwTy3VuST CIRCA-DOSE https://t…
RT @netta_doc: CAMERA-MRI https://t.co/dk9iRUwhsv CASTLE-AF https://t.co/l5hLrvLfdr CABANA https://t.co/CYwTy3VuST CIRCA-DOSE https://t…
RT @netta_doc: CAMERA-MRI https://t.co/dk9iRUwhsv CASTLE-AF https://t.co/l5hLrvLfdr CABANA https://t.co/CYwTy3VuST CIRCA-DOSE https://t…
RT @netta_doc: CAMERA-MRI https://t.co/dk9iRUwhsv CASTLE-AF https://t.co/l5hLrvLfdr CABANA https://t.co/CYwTy3VuST CIRCA-DOSE https://t…
RT @netta_doc: CAMERA-MRI https://t.co/dk9iRUwhsv CASTLE-AF https://t.co/l5hLrvLfdr CABANA https://t.co/CYwTy3VuST CIRCA-DOSE https://t…
CAMERA-MRI https://t.co/dk9iRUwhsv CASTLE-AF https://t.co/l5hLrvLfdr CABANA https://t.co/CYwTy3VuST CIRCA-DOSE https://t.co/XS0nGtJv0z Alcohol abstinence in AF https://t.co/Fevj4aKRfr #WAfib2020
Furthering upon catheter ablation therapy for atrial fibrillation and heart failure due to circuitous action potential transmission throughout the heart. #biom4180 https://t.co/ofyfIytpFp
@RogerAlvarezDO I think there is a selection issue and also quite a few who mistake the pleural of anecdote as being data. Also remember that #AFFIRM was looking at Asx AFib We do know that #afib ablation has benefits in pts w #HF: https://t.co/pEkw9mjc79
La respuesta estaría en la población? Solo los pacientes con falla cardiaca se benefician? https://t.co/HSQIuWllQ9
#AFib Modelling the lifetime cost-effectiveness of catheter ablation for atrial fibrillation with heart failure. https://t.co/qw1ymddrB6
RT @majazayeri: Other
RT @majazayeri: Other
RT @majazayeri: Other
RT @majazayeri: Other
Other
Inquietud genera también los resultados de la ablación en pacientes con falla cardiaca. El CASTLE HF demostró beneficio en el desenlace primario combinado. https://t.co/HSQIuWllQ9
RT @True_EP: @DanielAlyeshmer @NEJM @Dr_Santangeli @srissundaram @DrGregMichaud @Zo_EP2 @EJSMD @bogdienache @HamidGhanbariMD @KanwarAulakh…
@DanielAlyeshmer @NEJM @Dr_Santangeli @srissundaram @DrGregMichaud @Zo_EP2 @EJSMD @bogdienache @HamidGhanbariMD @KanwarAulakh @CarinaHardy4 Although it may seem intuitive that VT ablation would result in a mortality benefit, this has been difficult to prove. @DrRoderickTung is working on it though. If they have HF and also happen to have AF, then apparently AF ablation is life saving. https://t.co/gRLlO4YtIq
Catheter Ablation for Atrial Fibrillation with Heart Failure To know more : https://t.co/rtMD0TxgHr #cardiacgathering #cardiologymeeting #cardiacsurgerysummit #cardiaclife #heartdisease #Taipei #cardiacfact https://t.co/5Ca7sRM2i2
Aunque el CASTLE HF se considera un estudio positivo, las curvas de supervivencia solo se separan a los dos años luego del procedimiento. En este la población fue de pacientes con falla cardiaca. https://t.co/HSQIuWllQ9
@JagSinghMD Mortality benefit too https://t.co/xoknKe36uP
CASTLE-AF Trial Catheter Ablation for Atrial Fibrillation with Heart Failure https://t.co/pV1KYPLTcr https://t.co/8jMFdYbdUF
Uno de varios ensayos que demuestran la utilidad de la ablación en FA y falla cardíaca Catheter Ablation for Atrial Fibrillation with Heart Failure | NEJM https://t.co/pJcRP3MSWa https://t.co/t3vSBI0a1x
Very impressive results seen in new @NEJM study of catheter ablation for afib patients with heart failure. NNT: 1. Death (any cause): 8.6 2. HF hospitalization: 6.6 3. Primary outcome (1+2): 6.2 http://www.nejm.org/doi/full/10.1056/NEJMoa1707855?query=featured_home